Table 3.

Associations Between CKD in Subjects with MAFLD Complicated with DM

	p-value	Odds Ratio (95% CI)
Age	<0.001*	1.04 (1.02~1.07)
Hypertension	0.008*	1.78 (1.16~2.58)
Hyperuricemia	0.002*	2.08 (1.30~3.32)
ALP	0.138	1.01 (1.00, 1.01)
FIB-4 Score	0.985	1.00 (0.77~1.29)
NFS Score	0.357	1.10 (0.90~1.36)

Note: *A significant difference between groups.

Abbreviations: MAFLD, metabolic associated fatty liver disease; ALP, alkaline phosphatase; FIB-4, fibrosis-4; NFS, NAFLD fibrosis score.